» Articles » PMID: 22947584

Accuracy of Symptoms, Signs, and C-reactive Protein for Early Chronic Obstructive Pulmonary Disease

Overview
Journal Br J Gen Pract
Specialty Public Health
Date 2012 Sep 6
PMID 22947584
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Guidelines recommend detection of early chronic obstructive pulmonary disease (COPD), but evidence on the diagnostic work-up for COPD only concerns advanced and established COPD.

Aim: To quantify the accuracy of symptoms and signs for early COPD, and the added value of C-reactive protein (CRP), in primary care patients presenting with cough.

Design And Setting: Cross-sectional diagnostic study of 73 primary care practices in the Netherlands.

Method: Four hundred primary care patients (182 males, mean age 63 years) older than 50 years, presenting with persistent cough (>14 days) without established COPD participated, of whom 382 completed the study. They underwent a systematic diagnostic work-up of symptoms, signs, conventional laboratory CRP level, and hospital lung functions tests, including body plethysmography, and an expert panel decided whether COPD was present (reference test). The independent value of all items was estimated by multivariable logistic regression analysis.

Results: According to the expert panel, 118 patients had COPD (30%). Symptoms and signs with independent diagnostic value were age, sex, current smoking, smoking more than 20 pack-years, cardiovascular comorbidity, wheezing complaints, diminished breath sounds, and wheezing on auscultation. Combining these items resulted in an area under the receiver operating characteristic curve (ROC area) of 0.79 (95% confidence interval = 0.74 to 0.83) after internal validation. The proportion of subjects with elevated CRP was higher in those with early COPD, but CRP added no relevant diagnostic information above symptoms and signs.

Conclusion: In subjects presenting with persistent cough, the CRP level has no added value for detection of early COPD.

Citing Articles

Weighing the evidence for pharmacological treatment interventions in mild COPD; a narrative perspective.

Singh D, DUrzo A, Donohue J, Kerwin E Respir Res. 2019; 20(1):141.

PMID: 31286970 PMC: 6615221. DOI: 10.1186/s12931-019-1108-9.


Drop in lung function during asthma and COPD exacerbations - can it be assessed without spirometry?.

Melbye H, Al-Ani S, Spigt M Int J Chron Obstruct Pulmon Dis. 2016; 11:3145-3152.

PMID: 27994453 PMC: 5153253. DOI: 10.2147/COPD.S123315.


Laryngeal measurements and diagnostic tools for diagnosis of chronic obstructive pulmonary disease.

Casado V, Navarro S, Alvarez A, Villafane M, Miranda A, Spaans N Ann Fam Med. 2015; 13(1):49-52.

PMID: 25583892 PMC: 4291265. DOI: 10.1370/afm.1733.


Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.

Gupta D, Agarwal R, Aggarwal A, Maturu V, Dhooria S, Prasad K Lung India. 2013; 30(3):228-67.

PMID: 24049265 PMC: 3775210. DOI: 10.4103/0970-2113.116248.


Should chest examination be reinstated in the early diagnosis of chronic obstructive pulmonary disease?.

Oshaug K, Halvorsen P, Melbye H Int J Chron Obstruct Pulmon Dis. 2013; 8:369-77.

PMID: 23983462 PMC: 3751499. DOI: 10.2147/COPD.S47992.

References
1.
Buffels J, Degryse J, Heyrman J, Decramer M . Office spirometry significantly improves early detection of COPD in general practice: the DIDASCO Study. Chest. 2004; 125(4):1394-9. DOI: 10.1378/chest.125.4.1394. View

2.
Miller M, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A . Standardisation of spirometry. Eur Respir J. 2005; 26(2):319-38. DOI: 10.1183/09031936.05.00034805. View

3.
THIADENS H, de Bock G, Dekker F, Huysman J, van Houwelingen J, Springer M . Identifying asthma and chronic obstructive pulmonary disease in patients with persistent cough presenting to general practitioners: descriptive study. BMJ. 1998; 316(7140):1286-90. PMC: 28529. DOI: 10.1136/bmj.316.7140.1286. View

4.
van Durme Y, Verhamme K, Aarnoudse A, van Pottelberge G, Hofman A, Witteman J . C-reactive protein levels, haplotypes, and the risk of incident chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008; 179(5):375-82. DOI: 10.1164/rccm.200810-1540OC. View

5.
Karadag F, Kirdar S, Karul A, Ceylan E . The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease. Eur J Intern Med. 2008; 19(2):104-8. DOI: 10.1016/j.ejim.2007.04.026. View